Inter-Platform comparability of microarrays in acute lymphoblastic leukemia
<p>Abstract</p> <p>Background</p> <p>Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy and has been the poster-child for improved therapeutics in cancer, with life time disease-free survival (LTDFS) rates improving from <10% in 1970 to >80...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-09-01
|
Series: | BMC Genomics |
Online Access: | http://www.biomedcentral.com/1471-2164/5/71 |